Cannabinoids: chemistry and biology. Proceedings of a symposium. Bethesda, Maryland, USA. August 16-17, 2001. (2002) Chem Phys Lipids 121: 1-300
Proceedings of the Workshop on New Perspectives on Therapeutic Use of Endocannabinoids. Madrid, Spain. October 17-18, 2000. (2002) Pharmacol Ther 95: 101
Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, Makriyannis A (1994) (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37: 1889-1893
Abadji V, Lucas-Lenard JM, Chin C, Kendall DA (1999) Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs. J Neurochem 72: 2032-2038
Abdul-Rauf M, Ellar DJ (1999) Mutations of loop 2 and loop 3 residues in domain II of Bacillus thuringiensis Cry1C delta-endotoxin affect insecticidal specificity and initial binding to Spodoptera littoralis and Aedes aegypti midgut membranes. Curr Microbiol 39: 94-98
Abood ME, Ditto KE, Noel MA, Showalter VM, Tao Q (1997) Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells. Biochem Pharmacol 53: 207-214
Abood ME, Martin BR (1996) Molecular neurobiology of the cannabinoid receptor. Int Rev Neurobiol 39: 197-221
Abood ME, Rizvi G, Sallapudi N, McAllister SD (2001) Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci Lett 309: 197-201
Abraham IM, Han SK, Todman MG, Korach KS, Herbison AE (2003) Estrogen receptor beta mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. J Neurosci 23: 5771-5777
Abramson JJ, Zable AC, Favero TG, Salama G (1995) Thimerosal interacts with the Ca2+ release channel ryanodine receptor from skeletal muscle sarcoplasmic reticulum. J Biol Chem 270: 29644-29647
Aceto MD, Scates SM, Martin BB (2001) Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2. Eur J Pharmacol 416: 75-81
Aceto MD, Scates SM, Razdan RK, Martin BR (1998) Anandamide, an endogenous cannabinoid, has a very low physical dependence potential. J Pharmacol Exp Ther 287: 598-605
Achison M, Elton CM, Hargreaves PG, Knight CG, Barnes MJ, Farndale RW (2001) Integrin-independent tyrosine phosphorylation of p125(fak) in human platelets stimulated by collagen. J Biol Chem 276: 3167-3174
Acquas E, Pisanu A, Marrocu P, Goldberg SR, Di Chiara G (2001) Delta9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study. Eur J Pharmacol 419: 155-161
Adam J, Cowley P (2002) Recent advances in the cannabinoids. Expert Opinion on Therapeutic Patents 12: 1475-1489
Adami M, Frati P, Bertini S, Kulkarni-Narla A, Brown DR, de Caro G, Coruzzi G, Soldani G (2002) Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach. Br J Pharmacol 135: 1598-1606
Adams IB, Compton DR, Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284: 1209-1217
Adams IB, Martin BR (1996) Cannabis: pharmacology and toxicology in animals and humans. Addiction 91: 1585-1614
Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR (1995) Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sci 56: 2041-2048
Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR (1995) Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J Pharmacol Exp Ther 273: 1172-1181
Adams M, Montague CT, Prins JB, Holder JC, Smith SA, Sanders L, Digby JE, Sewter CP, Lazar MA, Chatterjee VK, O'Rahilly S (1997) Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J Clin Invest 100: 3149-3153
Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK (1997) Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem 272: 5128-5132
Ade K, Harvey-White J, Kunos G, Lovinger DM (2003) Developmental increase in the endogenous cannabinoid anandamide correlates with synaptic plasticity changes in the rat dorsolateral striatum. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Adkins CE, Morris SA, De Smedt H, Sienaert I, Torok K, Taylor CW (2000) Ca2+-calmodulin inhibits Ca2+ release mediated by type-1, -2 and -3 inositol trisphosphate receptors. Biochem J 345 Pt 2: 357-363
Adkins CE, Taylor CW (1999) Lateral inhibition of inositol 1,4,5-trisphosphate receptors by cytosolic Ca(2+). Curr Biol 9: 1115-1118
Adkins CE, Wissing F, Potter BV, Taylor CW (2000) Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A. Biochem J 352 Pt 3: 929-933
Adriani W, Caprioli A, Granstrem O, Carli M, Laviola G (2003) The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27: 639-651
Ahern GP (2003) Activation of TRPV1 by the satiety factor oleoylethanolamide. J Biol Chem 278: 30429-30434
Ahern GP, Premkumar LS (2002) Voltage-dependent priming of rat vanilloid receptor: effects of agonist and protein kinase C activation. J Physiol 545: 441-451
Ahluwalia J, Urban L, Bevan S, Capogna M, Nagy I (2002) Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones. Neuroscience 110: 747-753
Ahluwalia J, Urban L, Bevan S, Nagy I (2003) Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur J Neurosci 17: 2611-2618
Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I (2000) Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100: 685-688
Ahluwalia J, Yaqoob M, Urban L, Bevan S, Nagy I (2003) Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J Neurochem 84: 585-591
Ahmed SF, Cheng A, Hughes IA (1999) Assessment of the gonadotrophin-gonadal axis in androgen insensitivity syndrome. Arch Dis Child 80: 324-329
Akerman S, Kaube H, Goadsby PJ (2004) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309: 56-63
Akinshola BE, Chakrabarti A, Onaivi ES (1999) In-vitro and in-vivo action of cannabinoids. Neurochem Res 24: 1233-1240
Akinshola BE, Fryar EB, Taylor RE, Hanus L, Uhl GR, Onaivi ES (2002) Sensitivities of Endocannabinoids and Vanilloids: Substance Abuse Potential. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES (1999) Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol 360: 242-248
Akinshola BE, Wang H, Taylor RE, Onaivi ES (2000) Anandamide sensitivity of C-terminal mutant AMPA receptors. Society for Neuroscience Abstracts 26: Abstract No.-813.812
Al-Hayani A, Wease KN, Ross RA, Pertwee RG, Davies SN (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41: 1000-1005
Al-Lazikani B, Lesk AM, Chothia C (2000) Canonical structures for the hypervariable regions of T cell alphabeta receptors. J Mol Biol 295: 979-995
Alaoui El Azher M, Havet N, Singer M, Dumarey C, Touqui L (2000) Inhibition by unsaturated fatty acids of type II secretory phospholipase A2 synthesis in guinea-pig alveolar macrophages evidence for the eicosanoid-independent pathway. Eur J Biochem 267: 3633-3639
Alberich Jorda M, Rayman N, Tas M, Verbakel SE, Battista N, Van Lom K, Lowenberg B, Maccarrone M, Delwel R (2004) The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner. Blood
Alderson HL, Robbins TW, Everitt BJ (2000) Heroin self-administration under a second-order schedule of reinforcement: acquisition and maintenance of heroin-seeking behaviour in rats. Psychopharmacology (Berl) 153: 120-133
Alderton F, Fan TP, Humphrey PP (2001) Somatostatin receptor-mediated arachidonic acid mobilization: evidence for partial agonism of synthetic peptides. Br J Pharmacol 132: 760-766
Alexander DR (2000) The CD45 tyrosine phosphatase: a positive and negative regulator of immune cell function. Semin Immunol 12: 349-359
Alexander DR (2002) Kinase regulation: competing phosphatases in JAK dephosphorylation. Curr Biol 12: R288-290
Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68: 247-286
Alger BE, Isokawa M, Kim J (2003) Endocannabinoids and the regulation of synaptic inhibition. Journal of Neurochemistry 85
Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD (1998) Gender-linked brain injury in experimental stroke. Stroke 29: 159-165; discussion 166
Allen JP, Canty AJ, Schulz S, Humphrey PP, Emson PC, Young HM (2002) Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice. J Comp Neurol 454: 329-340
Allen JP, Hathway GJ, Clarke NJ, Jowett MI, Topps S, Kendrick KM, Humphrey PP, Wilkinson LS, Emson PC (2003) Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci 17: 1881-1895
Allen RL, Trowsdale J (2004) Recognition of classical and heavy chain forms of HLA-B27 by leukocyte receptors. Curr Mol Med 4: 59-65
Aloe L, Leon A, Levi-Montalcini R (1993) A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 39 Spec No: C145-147
Alonso R, Voutsinos B, Fournier M, Labie C, Steinberg R, Souilhac J, Le Fur G, Soubrie P (1999) Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function. Neuroscience 91: 607-620
Ambrosini A, Bertoli E, Mariani P, Tanfani F, Wozniak M, Zolese G (1993) N-acylethanolamines as membrane topological stress compromising agents. Biochim Biophys Acta 1148: 351-355
Ambrosini A, Tanfani F, Bertoli E, Wozniak M, Wypych Z, Zolese G (1993) Effect of N-acylethanolamines with different acyl-chains on DPPC multilamellar liposomes. Chem Phys Lipids 65: 165-169
Ambrosini A, Zolese G, Wozniak M, Genga D, Boscaro M, Mantero F, Balercia G (2003) Idiopathic infertility: susceptibility of spermatozoa to in-vitro capacitation, in the presence and the absence of palmitylethanolamide (a homologue of anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. Mol Hum Reprod 9: 381-388
Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348
Ameri A, Simmet T (2000) Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. Naunyn Schmiedebergs Arch Pharmacol 361: 265-272
Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126: 1831-1839
Anderson CN, Ohta K, Quick MM, Fleming A, Keynes R, Tannahill D (2003) Molecular analysis of axon repulsion by the notochord. Development 130: 1123-1133
Anderson RB, Holt CE (2002) Expression of UNC-5 in the developing Xenopus visual system. Mech Dev 118: 157-160
Andersson DA, Adner M, Hogestatt ED, Zygmunt PM (2002) Mechanisms underlying tissue selectivity of anandamide and other vanilloid receptor agonists. Mol Pharmacol 62: 705-713
Andersson H, D'Antona AM, Kendall DA, Von Heijne G, Chin CN (2003) Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. Mol Pharmacol 64: 570-577
Andersson M, Jacobsson SO, Jonsson KO, Tiger G, Fowler CJ (2000) Neurotoxicity of glutamate in chick telencephalon neurons: reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide. Arch Toxicol 74: 161-164
Andreiuk GM, Kisel MA, Litvinko NM (1997) [Effects of fatty acid amides on phosphatidylcholine hydrolysis catalyzed by phospholipase A2 in micelles]. Ukr Biokhim Zh 69: 32-36
Anggadiredja K, Nakamichi M, Hiranita T, Tanaka H, Shoyama Y, Watanabe S, Yamamoto T (2004) Endocannabinoid System Modulates Relapse to Methamphetamine Seeking: Possible Mediation by the Arachidonic Acid Cascade. Neuropsychopharmacology
Anggadiredja K, Yamaguchi T, Tanaka H, Shoyama Y, Watanabe S, Yamamoto T (2003) Prostaglandin E2 attenuates SR141716A-precipitated withdrawal in tetrahydrocannabinol-dependent mice. Brain Res 966: 47-53
Anikwue R, Huffman JW, Martin ZL, Welch SP (2002) Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. J Pharmacol Exp Ther 303: 340-346
Antonelli T, Tanganelli S, Tomasini MC, Finetti S, Trabace L, Steardo L, Sabino V, Carratu MR, Cuomo V, Ferraro L (2004) Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat. Neuroscience 124: 367-375
Anzai K, Ogawa K, Kuniyasu A, Ozawa T, Yamamoto H, Nakayama H (1998) Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem Biophys Res Commun 249: 938-942
Aoki K, Zubkov AY, Parent AD, Zhang JH (2000) Mechanism of ATP-induced [Ca(2+)](i) mobilization in rat basilar smooth muscle cells. Stroke 31: 1377-1384; discussion 1384-1375
Appendino G, Ligresti A, Minassi A, Daddario N, Bisogno T, Di Marzo V (2003) Homologues and isomers of noladin ether, a putative novel endocannabinoid: interaction with rat cannabinoid CB(1) receptors. Bioorg Med Chem Lett 13: 43-46
Arai Y, Fukushima T, Shirao M, Yang X, Imai K (2000) Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection. Biomed Chromatogr 14: 118-124
Arevalo-Martin A, Vela JM, Molina-Holgado E, Borrell J, Guaza C (2003) Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci 23: 2511-2516
Arias AM (2002) New alleles of Notch draw a blueprint for multifunctionality. Trends Genet 18: 168-170
Ariyoshi M, Schwabe JW (2003) A conserved structural motif reveals the essential transcriptional repression function of Spen proteins and their role in developmental signaling. Genes Dev 17: 1909-1920
Arizzi MN, Cervone KM, Aberman JE, Betz A, Liu Q, Lin S, Makriyannis A, Salamone JD (2004) Behavioral effects of inhibition of cannabinoid metabolism: The amidase inhibitor AM374 enhances the suppression of lever pressing produced by exogenously administered anandamide. Life Sci 74: 1001-1011
Arkowitz RA, Lowe N (1997) A small conserved domain in the yeast Spa2p is necessary and sufficient for its polarized localization. J Cell Biol 138: 17-36
Armour KL, van de Winkel JG, Williamson LM, Clark MR (2003) Differential binding to human FcgammaRIIa and FcgammaRIIb receptors by human IgG wildtype and mutant antibodies. Mol Immunol 40: 585-593
Arnaud P, Monk D, Hitchins M, Gordon E, Dean W, Beechey CV, Peters J, Craigen W, Preece M, Stanier P, Moore GE, Kelsey G (2003) Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark. Hum Mol Genet 12: 1005-1019
Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132: 104-106
Arnould S, Takahashi M, Camadro JM (1999) Acylation stabilizes a protease-resistant conformation of protoporphyrinogen oxidase, the molecular target of diphenyl ether-type herbicides. Proc Natl Acad Sci U S A 96: 14825-14830
Arreaza G, Deutsch DG (1999) Deletion of a proline-rich region and a transmembrane domain in fatty acid amide hydrolase. FEBS Lett 454: 57-60
Arreaza G, Devane WA, Omeir RL, Sajnani G, Kunz J, Cravatt BF, Deutsch DG (1997) The cloned rat hydrolytic enzyme responsible for the breakdown of anandamide also catalyzes its formation via the condensation of arachidonic acid and ethanolamine. Neurosci Lett 234: 59-62
Asai S, Noda M, Yamamura M, Hozumi Y, Takase I, Nitta H, Sato M, Namikawa I (1993) Comparative study of the cellular fatty acids of methicillin-resistant and -susceptible Staphylococcus aureus. Apmis 101: 753-761
Ashwood VA, Field MJ, Horwell DC, Julien-Larose C, Lewthwaite RA, McCleary S, Pritchard MC, Raphy J, Singh L (2001) Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK(1) receptor antagonist. J Med Chem 44: 2276-2285
Ates M, Hamza M, Seidel K, Kotalla CE, Ledent C, Guhring H (2003) Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Eur J Neurosci 17: 597-604
Augood SJ, Faull RL, Emson PC (1992) Contrasting Effects of Raclopride and SCH 23390 on the Cellular Content of Preproenkephalin A mRNA in Rat Striatum: A Quantitative Non-radioactive In Situ Hybridization Study. Eur J Neurosci 4: 102-112
Augood SJ, Hollingsworth ZR, Standaert DG, Emson PC, Penney JB, Jr. (2000) Localization of dopaminergic markers in the human subthalamic nucleus. J Comp Neurol 421: 247-255
Augustine GJ, Adler EM, Charlton MP (1991) The calcium signal for transmitter secretion from presynaptic nerve terminals. Ann N Y Acad Sci 635: 365-381
Augustine GJ, Charlton MP, Smith SJ (1987) Calcium action in synaptic transmitter release. Annu Rev Neurosci 10: 633-693
Augustine GJ, Neher E (1992) Neuronal Ca2+ signalling takes the local route. Curr Opin Neurobiol 2: 302-307
Austin-Brown SL, Chapman KD (2002) Inhibition of phospholipase D alpha by N-acylethanolamines. Plant Physiol 129: 1892-1898
Axelrod J, Felder CC (1998) Cannabinoid receptors and their endogenous agonist, anandamide. Neurochem Res 23: 575-581
Azad S, Zieglgansberger W, Kurz J, Rammes G (2003) Cannabinoid - induced modulation of inwardly rectifying potassium channels and N - type calcium channels inhibits long - term depression in the lateral amygdala of the mouse. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Azad SC, Eder M, Marsicano G, Lutz B, Zieglgansberger W, Rammes G (2003) Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 10: 116-128
Azad SC, Marsicano G, Eberlein I, Putzke J, Zieglgansberger W, Spanagel R, Lutz B (2001) Differential role of the nitric oxide pathway on delta(9)-THC-induced central nervous system effects in the mouse. Eur J Neurosci 13: 561-568